An Assessment of EGFR and HER2 Inhibitors with Structure Activity Relationship of Fused Pyrimidine Derivatives for Breast Cancer: A Brief Review

The authors gather some results for fused-pyrimidine derivatives on various cancerous cell lines and animal evaluation to highlight their potency.